Obesity Clinical Trial
Official title:
The Effect of Regular Kefir Consumption on Metabolic Syndrome Parameters, Inflammatory Response, and Gut Microbiota: A Parallel-Group, Randomized, Controlled Clinical Study
NCT number | NCT03966846 |
Other study ID # | 152114 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2015 |
Est. completion date | July 2017 |
Verified date | May 2019 |
Source | Izmir Katip Celebi University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Metabolic syndrome is a cluster of metabolic disorders which increases the risk for diabetes and cardiovascular disease. In recent years, research has shown that probiotics may have positive effects on metabolic syndrome components. Although several health-promoting effects of kefir, have been suggested, there is limited evidence for its potential effect on metabolic syndrome. Therefore, it is necessary to clarify the effects of kefir on metabolic disorders including obesity, dyslipidemia, diabetes, and hypertension. To address the research gap, this study aimed to investigate the effects of daily kefir consumption on metabolic syndrome components, inflammatory response and gut microbiota composition in adults with MetS. The study was planned as a randomized, controlled, parallel design and completed with a total of 62 individuals who were diagnosed with metabolic syndrome according to the International Diabetes Federation (IDF) criteria. Participants were randomized into two groups and received daily 180 ml of kefir (n=31) or milk (as control) (n=31) for 12 weeks. Participants were assessed at baseline, week 4, week 8, and week 12 and at all controls dietary records, anthropometric measurements, and blood samples were collected. At baseline and 12th-week fecal samples were also collected in order to analyze gut microbiota composition.
Status | Completed |
Enrollment | 62 |
Est. completion date | July 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - 18-65 years old subjects - Subjects diagnosed with metabolic syndrome according to the International Diabetes Federation (IDF) criteria. Exclusion Criteria: - Existence of lactose intolerance - Existence of type 1 diabetes - Existence of abnormal thyroid hormone levels - Existence of chronic gastrointestinal system disease - Existence of cancer - Existence of severe liver disease - Existence of kidney insufficiency - Existence of immunodeficiency - Taking medication to regulate blood glucose (except metformin) or lipid levels - Taking antibiotics prior to one month of the study - Consuming regular probiotic food or supplement - Taking supplement which may affect the metabolic outcomes such as prebiotic or omega-3 - Dieting for weight loss or for another disease - Being pregnant and breastfeeding. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Izmir Katip Celebi University | Ege University, Hacettepe University, Turkey Council of Higher Education Teaching Stuff Training Program |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in lipid profile | Measurement of lipid profile (HDL cholesterol, triglyceride levels) | baseline, week 4, week 8 and week 12 | |
Primary | Changes in glycemic profile | Measurement of fasting glucose, insulin, and calculation of HOMA-IR | baseline, week 4, week 8 and week 12 | |
Primary | Changes in gut microbiota | Determine the profile of gut flora (% abundance of various bacterial phyla, families, genera and species) | week 0- week 12 | |
Secondary | Changes in Inflammatory Parametres | Measurement of serum cytokines levels (high sensitive serum C- reactive protein ,TNF-a, IL-6, IL-10 ve IFN-?) | baseline and week 12 | |
Secondary | Changes in serum cholesterol levels | Measurement of total cholesterol and its fractions (mg/dl) | baseline, week 4, week 8 and week 12 | |
Secondary | Changes in triglycerides | Measurement of serum triglyceride (mg/dl) | baseline, week 4, week 8 and week 12 | |
Secondary | Changes in lipoproteins | Measurement of lipoproteins (mg/dl) (apolipoprotein A1, apolipoprotein B, lipoprotein (a)) | baseline and week 12 | |
Secondary | Changes in homocysteine | Measurement of homocysteine (umol/L) | baseline and week 12 | |
Secondary | Changes in glycated hemoglobin | Measurement of HbA1c (%) | baseline and week 12 | |
Secondary | Changes in blood pressure | Measurement of systolic and diastolic blood pressure (mm Hg) | baseline, week 4, week 8 and week 12 | |
Secondary | Changes in waist circumference | Measurement of waist circumference (cm) | baseline, week 4, week 8 and week 12 | |
Secondary | Changes in Body Fat | Measurement of % body fat with BIA | baseline, week 4, week 8 and week 12 | |
Secondary | Changes in BMI | weight and height will be measured to report BMI in kg/m2 | baseline, week 4, week 8 and week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |